Compounds that contain the radical R2C=N.OH derived from condensation of ALDEHYDES or KETONES with HYDROXYLAMINE. Members of this group are CHOLINESTERASE REACTIVATORS.
Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.
A gamma-emitting RADIONUCLIDE IMAGING agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and MYOCARDIAL PERFUSION IMAGING. It has also been used to label leukocytes in the investigation of INFLAMMATORY BOWEL DISEASES.
Cholinesterase reactivator occurring in two interchangeable isomeric forms, syn and anti.
Poisoning due to exposure to ORGANOPHOSPHORUS COMPOUNDS, such as ORGANOPHOSPHATES; ORGANOTHIOPHOSPHATES; and ORGANOTHIOPHOSPHONATES.
Agents counteracting or neutralizing the action of POISONS.
Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE.
Carbon-containing phosphoric acid derivatives. Included under this heading are compounds that have CARBON atoms bound to one or more OXYGEN atoms of the P(=O)(O)3 structure. Note that several specific classes of endogenous phosphorus-containing compounds such as NUCLEOTIDES; PHOSPHOLIPIDS; and PHOSPHOPROTEINS are listed elsewhere.
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7.
An organophosphorus ester compound that produces potent and irreversible inhibition of cholinesterase. It is toxic to the nervous system and is a chemical warfare agent.
Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.
Pyridinium compounds are organic salts formed when pyridine, a basic heterocyclic organic compound, reacts with acids, resulting in a positively charged nitrogen atom surrounded by aromatic rings.
An organophosphate cholinesterase inhibitor that is used as a pesticide.
Organic compounds that contain the (-NH2OH) radical.
A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.
The collective name for the boron hydrides, which are analogous to the alkanes and silanes. Numerous boranes are known. Some have high calorific values and are used in high-energy fuels. (From Grant & Hackh's Chemical Dictionary, 5th ed)
An aspect of cholinesterase (EC 3.1.1.8).
The reactions and interactions of atoms and molecules, the changes in their structure and composition, and associated energy changes.
Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS.

Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. (1/945)

This study was designed to determine the magnitude and time course of platelet activation during therapy of acute coronary syndromes with an oral platelet antagonist. BACKGROUND: Platelet activation and aggregation are central to the pathogenesis of the acute coronary syndromes (ACS). However, few data are available on levels of platelet activation over time in patients with ACS, especially in the setting of chronic glycoprotein (GP) IIb/IIIa inhibition. METHODS: The Thrombolysis in Myocardial Infarction (TIMI) 12 trial was a phase II, double-blind trial evaluating the effects of sibrafiban, an oral, selective antagonist of the platelet glycoprotein IIb/IIIa receptor in patients stabilized after an ACS. A subset of 90 of the 329 patients in the study had measurement of platelet activation as assessed by the expression of platelet associated P-Selectin on days 0, 7 and 28. Platelet activation was measured in blood samples that were fixed either immediately (spontaneous activation) or after 5 minute incubation with 0, 1 microM or 5 microM ADP in order to assess platelet responsiveness to very low or moderate stimulation. RESULTS: At baseline there was a significant elevation of spontaneous platelet activation as compared to samples obtained from normal donors or from patients who did not have acute coronary syndromes (ACS patients 27.6+/-18.7%, Normal controls 8.5+/-4.4%, Patient controls 10.9+/-7.1%, p < 0.005 for both). In addition, there was a significant decrease in the levels of platelet activation with time during the 28 days of treatment with sibrafiban. Nevertheless, even on day 28, the TIMI-12 patients continued to show elevated platelet activation in comparison to the control groups (p < 0.05 for both). CONCLUSIONS: These results suggest that platelets remain activated long after clinical stabilization post ACS. Although platelet activation decreased after one month of oral GPIIb/IIIa inhibition, levels remained higher than normal, suggesting the need for long-term antiplatelet therapy following ACS.  (+info)

Slow oxidation of acetoxime and methylethyl ketoxime to the corresponding nitronates and hydroxy nitronates by liver microsomes from rats, mice, and humans. (2/945)

Acetoxime and methylethyl ketoxime (MEKO) are tumorigenic in rodents, inducing liver tumors in male animals. The mechanisms of tumorigenicity for these compounds are not well defined. Oxidation of the oximes to nitronates of secondary-nitroalkanes, which are mutagenic and tumorigenic in rodents, has been postulated to play a role in the bioactivation of ketoximes. In these experiments, we have compared the oxidation of acetoxime and methylethyl ketoxime to corresponding nitronates in liver microsomes from different species. The oximes were incubated with liver microsomes from mice, rats, and several human liver samples. After tautomeric equilibration and extraction with n-hexane, 2-nitropropane and 2-nitrobutane were quantitated by GC/MS-NCI (limit of detection of 250 fmol/injection volume). In liver microsomes, nitronate formation from MEKO and acetoxime was dependent on time, enzymatically active proteins, and the presence of NADPH. Nitronate formation was increased in liver microsomes of rats pretreated with inducers of cytochrome P450 and reduced in the presence of inhibitors (n-octylamine and diethyldithiocarbamate). Rates of oxidation of MEKO (Vmax) were 1.1 nmol/min/mg (mice), 0.5 nmol/min/mg (humans), and 0.1 nmol/min/mg (rats). In addition to nitronates, several minor metabolites were also enzymatically formed (two diastereoisomers of 3-nitro-2-butanol, 2-hydroxy-3-butanone oxime and 2-nitro-1-butanol). Acetoxime was also metabolized to the corresponding nitronate at rates approximately 50% of those observed with MEKO oxidation in the three species examined. 2-Nitro-1-propanol was identified as a minor product formed from acetoxime. No sex differences in the capacity to oxidize acetoxime and MEKO were observed in the species examined. The observed results show that formation of sec-nitronates from ketoximes occurs slowly, but is not the only pathway involved in the oxidative biotransformation of these compounds. Due to the lack of sex-specific oxidative metabolism, other metabolic pathways or mechanisms of tumorigenicity not involving bioactivation may be involved in the sex-specific tumorigenicity of ketoximes in rodents.  (+info)

Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia. (3/945)

To elucidate the applicability of 99mTc-HL91 (HL91) a putative hypoxic tracer, to the imaging of hypoxia in tumors, a biodistribution study of the tracer was performed. The intratumoral distribution of HL91 was compared with that of 14C-deoxyglucose (DG) and the expression of glucose transporter 1 (GLUT1) in an implanted tumor. METHODS: Biodistribution of HL91 after intravenous injection into Wistar rats with rat mammary tumor (Walker-256) was studied by determining blood and tissue levels of radioactivity from 15 min to 6 h after injection. Dual ex vivo autoradiography was performed on sections of the tumor using HL91 (74 MBq) and DG (185 kBq). The same sections were immunohistologically analyzed with anti-GLUT1 antibody. Tumor tissue was histologically divided into areas of viable cancer cells, necrosis and granulation tissue. The viable cancer cell area was further divided into normoxic and hypoxic areas. Uptake of both tracers in each area was measured quantitatively. The intensity of GLUT1 staining (relative optical density [ROD]) in each area was evaluated by densitometry. RESULTS: The uptake of HL91 in the tumor reached a maximal value (0.897 +/- 0.118% ID [injected dose], mean +/- SD, n = 5) at 120 min after intravenous injection of HL91, then gradually decreased. The tumor-to-muscle ratio continued to increase until 360 min (4.34 at 120 min, 7.01 at 240 min and 10.4 at 360 min). HL91 accumulated to significantly higher levels in the hypoxic area than those in the other tissues (P < 0.0001). Uptake of DG and expression of GLUT1 were significantly higher in the hypoxic area than in the normoxic area (P < 0.0001). In the viable cancer cell area, uptake of HL91 and expression of GLUT1 were strongly correlated (r = 0.624-0.868, mean r = 0.743, P < 0.0001), and DG uptake was moderately correlated with GLUT1 expression (r = 0.328-0.669, mean r = 0.505, P < 0.0001). CONCLUSION: These results indicate that HL91 can be used to detect tumor hypoxia.  (+info)

Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers. (4/945)

AIMS: This study constituted the first administration of the oral platelet inhibitor, sibrafiban, to humans. The aim was to investigate the pharmacokinetics and pharmacodynamics of Ro 44-3888, the active principle of sibrafiban, after single ascending oral doses of sibrafiban. Particular emphasis was placed on intersubject variability of the pharmacokinetic and pharmacodynamic parameters of Ro 44-3888. METHODS: The study consisted of three parts. Part I was an open ascending-dose study to determine target effect ranges of sibrafiban. Part II, a double-blind, placebo-controlled, parallel-group study, addressed the intersubject variability of pharmacokinetic and pharmacodynamic parameters of the active principle at a sibrafiban dose achieving an intermediate effect. Part III was a double-blind, placebo-controlled, ascending-dose design covering the complete plasma concentration vs pharmacodynamic response curve of sibrafiban. RESULTS: At sibrafiban doses between 5 mg and 12 mg, the pharmacokinetics of free Ro 44-3888 in plasma were linear whereas those of total Ro 44-3888 were non-linear because of the saturable binding to the glycoprotein IIb-IIIa receptor. Saturation of the GP IIb-IIIa receptor was reached at plasma concentrations of 15.9 ng ml-1. At sibrafiban doses up to 2 mg, ADP-induced platelet aggregation was inhibited by 50%, whereas the inhibition of TRAP-induced platelet aggregation was about 20-30%. At the higher doses, ADP-induced platelet aggregation was almost completely inhibited while a clear dose-response could be observed with TRAP-induced inhibition of platelet aggregation at sibrafiban doses of 5 to 12 mg. Ivy bleeding time increased very steeply with dose with a significant prolongation observed at doses of 5 to 7 mg of sibrafiban (5-7 min, >30 min in one case). At a sibrafiban dose of 12 mg, the stopping criterion for dose escalation (prolongation of the Ivy bleeding time >30 min in three out of four subjects per dose group) was reached. The interindividual coefficients of variation of the integrated pharmacokinetic and pharmacodynamic parameters (AUC and AUE) were below 20%, thus lying well within the pre-set level of acceptance. CONCLUSIONS: With a low intersubject variability of its pharmacokinetic and pharmacodynamic parameters, linear pharmacokinetics and pharmacodynamic effects closely related to its plasma concentrations, Ro 44-3888 has good pharmacological prerequisites for a well controllable therapy of secondary prevention of arterial thrombosis in patients with acute coronary syndrome.  (+info)

GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine. (5/945)

A procedure for the simultaneous confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine specimens by gas chromatography-mass spectrometry (GC-MS) is described. After the addition of nalorphine and naltrexone as the two internal standards, the urine is hydrolyzed overnight with beta-glucuronidase from E. coli. The urine is adjusted to pH 9 and extracted with 8% trifluoroethanol in methylene dichloride. After evaporating the organic, the residue is sequentially derivatized with 2% methoxyamine in pyridine, then with propionic anhydride. The ketone groups on hydrocodone, hydromorphone, oxycodone, oxymorphone, and naltrexone are converted to their respective methoximes. Available hydroxyl groups on the O3 and O6 positions are converted to propionic esters. After a brief purification step, the extracts are analyzed by GC-MS using full scan electron impact ionization. Nalorphine is used as the internal standard for codeine, morphine, and 6-acetylmorphine; naltrexone is used as the internal standard for the 6-keto-opioids. The method is linear to 2000 ng/mL for the 6-keto-opioids and to 5000 ng/mL for the others. The limit of quantitation is 25 ng/mL in hydrolyzed urine. Day-to-day precision at 300 and 1500 ng/mL ranged between 6 and 10.9%. The coefficients of variation for 6-acetylmorphine were 12% at both 30 and 150 ng/mL. A list of 38 other basic drugs or metabolites detected by this method is tabulated.  (+info)

Nitrile hydratase involved in aldoxime metabolism from Rhodococcus sp. strain YH3-3 purification and characterization. (6/945)

Nitrile hydratase responsible for aldoxime metabolism from the E-pyridine-3-aldoxime degrading bacterium, Rhodococcus sp. strain YH3-3 was purified and characterized. Addition of cobalt ion was necessary for the formation of enzyme. The enzyme activity was highly induced not only by nitriles and amides but also by several aldoxime compounds. The enzyme was purified approximately 108-fold with a 16% yield from the cell-free extract of the strain. The native enzyme had a Mr of approximately 130 000 and consisted of two subunits (alpha-subunit, 27 100; beta-subunit, 34 500). The enzyme contained approximately 2 mol cobalt per mol enzyme; it showed a maximum activity at 60 degrees C and at 40 degrees C under the rate assay and end-point assay conditions, respectively, and was stable over a wide range of pH (pH 2.5-11.0). The enzyme had a wide substrate specificity: it acted on aliphatic saturated and unsaturated as well as aromatic nitriles. The N-terminus of the beta-subunit showed good sequence similarities with those of other nitrile hydratases. Nitrile hydratase is part of the metabolic pathway for aldoximes in microorganisms.  (+info)

A novel potential application for 99mTc-HMPAO: endothelial cell labeling for in vitro investigation of cell-biomaterial interactions. (7/945)

Good adherence of endothelial cells (ECs) seeded on vascular prostheses and cell retention under flow conditions are important factors to consider in the use of functionalized prostheses in vascular surgery. Because 111In-oxine radiolabeling presents disadvantages, we wondered whether, because of its well-known physical properties, 99mTc-hexamethyl propyleneamine oxime (HMPAO or exametazime) could be used. METHODS: The cytotoxicity of unlabeled HMPAO and 99mTc-HMPAO at increasing concentrations and activities was tested on monolayers of the EC line EA-hy-926. The influence of temperature and time on tracer incorporation into cells was also tested. The optimal labeling conditions were applied to evaluate the retention of ECs seeded on polyester grafts under flow conditions by gamma camera detection. RESULTS: The activity of 10 MBq/10(6) cells corresponding to 4.5 microg/10(6) cells of unlabeled HMPAO, applied for 3 h at 37 degrees C (cellular uptake = 18%), was the best compromise between the maintenance of cell viability and metabolic activity and efficient detection by the gamma camera. Spontaneous leakage was observed and analyzed by high-performance liquid chromatography. A cell loss of 13% after 180-min exposure to shear stress was obtained. CONCLUSION: Our data thus indicate the feasibility of using such a radiolabeling technique to investigate EC-biomaterial interactions.  (+info)

Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization. (8/945)

Milameline (E-1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxaldehyde, O-methyloxime monohydrochloride, CI-979, PD129409, RU35926) was characterized in vitro and evaluated for effects on central and peripheral cholinergic activity in rats and rhesus monkeys. In muscarinic binding studies, milameline displayed nanomolar affinity with an agonist ligand and micromolar affinity with antagonist ligands, with approximately equal affinities determined at the five subtypes of human muscarinic receptors (hM(1)-hM(5)) with whole cells or membranes from stably transfected Chinese hamster ovary (CHO) cells. On binding, milameline stimulated phosphatidylinositol hydrolysis in hM(1) and hM(3) CHO cells and inhibited forskolin-activated cAMP accumulation in hM(2) and hM(4) CHO cells. Additionally, it decreased K(+)-stimulated release of [(3)H]acetylcholine from rat cortical slices. Responses were not caused by the inhibition of acetylcholinesterase, and there was no significant binding to approximately 30 other neurotransmitter binding sites. In rats, milameline decreased spontaneous and scopolamine-induced swimming activity, improved water-maze performance of animals impaired by basal forebrain lesions, increased cortical blood flow, decreased core body temperature, and increased gastrointestinal motility. Electroencephalogram activity in both rats and monkeys was characterized by a predominance of low-voltage desynchronized activity consistent with an increase in arousal. Milameline also reversed a scopolamine-induced impairment of attention on a continuous-performance task in monkeys. Thus, milameline possesses a pharmacological profile consistent with that of a partial muscarinic agonist, with central cholinergic actions being produced in rats and monkeys at doses slightly lower than those stimulating peripheral cholinergic receptors.  (+info)

Oximes are a class of chemical compounds that contain the functional group =N-O-, where two organic groups are attached to the nitrogen atom. In a clinical context, oximes are used as antidotes for nerve agent and pesticide poisoning. The most commonly used oxime in medicine is pralidoxime (2-PAM), which is used to reactivate acetylcholinesterase that has been inhibited by organophosphorus compounds, such as nerve agents and certain pesticides. These compounds work by forming a bond with the phosphoryl group of the inhibited enzyme, allowing for its reactivation and restoration of normal neuromuscular function.

Cholinesterase reactivators are a type of medication used to reverse the effects of certain types of poisoning, particularly organophosphate and carbamate pesticides, as well as nerve agents. These chemicals work by inhibiting the enzyme acetylcholinesterase, which normally breaks down the neurotransmitter acetylcholine in the body. This can lead to an overaccumulation of acetylcholine and result in symptoms such as muscle weakness, seizures, and respiratory failure.

Cholinesterase reactivators, also known as oximes, work by reactivating the inhibited enzyme and allowing it to resume its normal function. The most commonly used cholinesterase reactivator is pralidoxime (2-PAM), which is often administered in combination with atropine to treat organophosphate poisoning.

It's important to note that cholinesterase reactivators are not effective against all types of nerve agents or pesticides, and their use should be determined by a medical professional based on the specific type of poisoning involved. Additionally, these medications can have side effects and should only be administered under medical supervision.

Technetium Tc 99m Exametazime is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound consists of the radioisotope Technetium-99m (^99m^Tc) bonded to Exametazime, also known as HMPAO (hexamethylpropyleneamine oxime).

Once injected into the patient's bloodstream, Technetium Tc 99m Exametazime distributes evenly throughout the brain, crossing the blood-brain barrier and entering cells. The radioactive decay of Technetium-99m emits gamma rays that can be detected by a gamma camera, creating images of the brain's blood flow and distribution of the tracer.

This imaging technique is often used in cerebral perfusion studies to assess conditions such as stroke, epilepsy, or dementia, providing valuable information about regional cerebral blood flow and potential areas of injury or abnormality.

Obidoxime chloride is a medication that belongs to the class of drugs known as oximes. It is used as an antidote for nerve agent and organophosphate poisoning. Obidoxime works by reactivating the inhibited acetylcholinesterase enzyme, which is essential for normal functioning of the nervous system. This enzyme can be inhibited by nerve agents and organophosphates, leading to an overstimulation of the nervous system that can result in symptoms such as muscle weakness, seizures, respiratory failure, and death.

Obidoxime is administered intravenously and works by breaking down the bond between the nerve agent or organophosphate and the acetylcholinesterase enzyme, allowing the enzyme to function normally again. It is important to note that obidoxime should be administered as soon as possible after exposure to a nerve agent or organophosphate in order to be effective.

It's important to mention that Obidoxime Chloride is not used frequently and only in specific situations, it requires medical supervision and administration by trained healthcare professionals.

Organophosphate (OP) poisoning refers to the toxic effects that occur after exposure to organophosphate compounds, which are commonly used as pesticides, nerve agents, and plasticizers. These substances work by irreversibly inhibiting acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine in the nervous system. As a result, excessive accumulation of acetylcholine leads to overstimulation of cholinergic receptors, causing a wide range of symptoms.

The severity and type of symptoms depend on the dose, duration, and route of exposure (inhalation, ingestion, or skin absorption). The primary manifestations of organophosphate poisoning are:

1. Muscarinic effects: Excess acetylcholine at muscarinic receptors in the parasympathetic nervous system results in symptoms such as narrowed pupils (miosis), increased salivation, lacrimation, sweating, bronchorrhea (excessive respiratory secretions), diarrhea, bradycardia (decreased heart rate), and hypotension.
2. Nicotinic effects: Overstimulation of nicotinic receptors at the neuromuscular junction leads to muscle fasciculations, weakness, and paralysis. This can also cause tachycardia (increased heart rate) and hypertension.
3. Central nervous system effects: OP poisoning may result in headache, dizziness, confusion, seizures, coma, and respiratory depression.

Treatment for organophosphate poisoning includes decontamination, supportive care, and administration of antidotes such as atropine (to block muscarinic effects) and pralidoxime (to reactivate acetylcholinesterase). Delayed treatment can lead to long-term neurological damage or even death.

An antidote is a substance that can counteract the effects of a poison or toxin. It works by neutralizing, reducing, or eliminating the harmful effects of the toxic substance. Antidotes can be administered in various forms such as medications, vaccines, or treatments. They are often used in emergency situations to save lives and prevent serious complications from poisoning.

The effectiveness of an antidote depends on several factors, including the type and amount of toxin involved, the timing of administration, and the individual's response to treatment. In some cases, multiple antidotes may be required to treat a single poisoning incident. It is important to note that not all poisons have specific antidotes, and in such cases, supportive care and symptomatic treatment may be necessary.

Examples of common antidotes include:

* Naloxone for opioid overdose
* Activated charcoal for certain types of poisoning
* Digoxin-specific antibodies for digoxin toxicity
* Fomepizole for methanol or ethylene glycol poisoning
* Dimercaprol for heavy metal poisoning.

Chemical warfare agents are defined as chemical substances that are intended or have the capability to cause death, injury, temporary incapacitation, or sensory irritation through their toxic properties when deployed in a military theater. These agents can be in gaseous, liquid, or solid form and are typically categorized based on their physiological effects. Common categories include nerve agents (e.g., sarin, VX), blister agents (e.g., mustard gas), choking agents (e.g., phosgene), blood agents (e.g., cyanide), and incapacitating agents (e.g., BZ). The use of chemical warfare agents is prohibited by international law under the Chemical Weapons Convention.

Organophosphates are a group of chemicals that include insecticides, herbicides, and nerve gases. They work by inhibiting an enzyme called acetylcholinesterase, which normally breaks down the neurotransmitter acetylcholine in the synapse between nerves. This leads to an overaccumulation of acetylcholine, causing overstimulation of the nervous system and resulting in a wide range of symptoms such as muscle twitching, nausea, vomiting, diarrhea, sweating, confusion, and potentially death due to respiratory failure. Organophosphates are highly toxic and their use is regulated due to the risks they pose to human health and the environment.

Cholinesterase inhibitors are a class of drugs that work by blocking the action of cholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine in the body. By inhibiting this enzyme, the levels of acetylcholine in the brain increase, which can help to improve symptoms of cognitive decline and memory loss associated with conditions such as Alzheimer's disease and other forms of dementia.

Cholinesterase inhibitors are also used to treat other medical conditions, including myasthenia gravis, a neuromuscular disorder that causes muscle weakness, and glaucoma, a condition that affects the optic nerve and can lead to vision loss. Some examples of cholinesterase inhibitors include donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon).

It's important to note that while cholinesterase inhibitors can help to improve symptoms in some people with dementia, they do not cure the underlying condition or stop its progression. Side effects of these drugs may include nausea, vomiting, diarrhea, and increased salivation. In rare cases, they may also cause seizures, fainting, or cardiac arrhythmias.

Acetylcholinesterase (AChE) is an enzyme that catalyzes the hydrolysis of acetylcholine (ACh), a neurotransmitter, into choline and acetic acid. This enzyme plays a crucial role in regulating the transmission of nerve impulses across the synapse, the junction between two neurons or between a neuron and a muscle fiber.

Acetylcholinesterase is located in the synaptic cleft, the narrow gap between the presynaptic and postsynaptic membranes. When ACh is released from the presynaptic membrane and binds to receptors on the postsynaptic membrane, it triggers a response in the target cell. Acetylcholinesterase rapidly breaks down ACh, terminating its action and allowing for rapid cycling of neurotransmission.

Inhibition of acetylcholinesterase leads to an accumulation of ACh in the synaptic cleft, prolonging its effects on the postsynaptic membrane. This can result in excessive stimulation of cholinergic receptors and overactivation of the cholinergic system, which may cause a range of symptoms, including muscle weakness, fasciculations, sweating, salivation, lacrimation, urination, defecation, bradycardia, and bronchoconstriction.

Acetylcholinesterase inhibitors are used in the treatment of various medical conditions, such as Alzheimer's disease, myasthenia gravis, and glaucoma. However, they can also be used as chemical weapons, such as nerve agents, due to their ability to disrupt the nervous system and cause severe toxicity.

Sarin is a potent and deadly nerve agent, a type of organic compound called a phosphoro-organic fluid. It is a colorless, odorless, and tasteless liquid, which is also known as GB. Sarin is a human-made chemical warfare agent that is considered a weapon of mass destruction and is banned under the Chemical Weapons Convention of 1993.

Sarin works by inhibiting the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine in the body. This leads to an overaccumulation of acetylcholine at the neuromuscular junctions and synapses, causing uncontrolled muscle contractions, paralysis, respiratory failure, and ultimately death if not treated promptly.

Exposure to Sarin can occur through inhalation, skin contact, or ingestion. Symptoms of exposure include runny nose, tightness in the chest, difficulty breathing, nausea, vomiting, diarrhea, blurred vision, and confusion. Immediate medical attention is required for anyone exposed to Sarin, as antidotes such as atropine and pralidoxime can be administered to counteract its effects.

Organotechnetium compounds are chemical substances that contain carbon-technetium bonds, where technetium is an element with the symbol Tc and atomic number 43. These types of compounds are primarily used in medical imaging as radioactive tracers due to the ability of technetium-99m to emit gamma rays. The organotechnetium compounds help in localizing specific organs, tissues, or functions within the body, making them useful for diagnostic purposes in nuclear medicine.

It is important to note that most organotechnetium compounds are synthesized from technetium-99m, which is generated from the decay of molybdenum-99. The use of these compounds requires proper handling and administration by trained medical professionals due to their radioactive nature.

Pyridinium compounds are organic salts that contain a positively charged pyridinium ion. Pyridinium is a type of cation that forms when pyridine, a basic heterocyclic organic compound, undergoes protonation. The nitrogen atom in the pyridine ring accepts a proton (H+) and becomes positively charged, forming the pyridinium ion.

Pyridinium compounds have the general structure of C5H5NH+X-, where X- is an anion or negatively charged ion. These compounds are often used in research and industry, including as catalysts, intermediates in chemical synthesis, and in pharmaceuticals. Some pyridinium compounds have been studied for their potential therapeutic uses, such as in the treatment of bacterial infections or cancer. However, it is important to note that some pyridinium compounds can also be toxic or reactive, so they must be handled with care.

Paraoxon is the active metabolite of the organophosphate insecticide parathion. It functions as an acetylcholinesterase inhibitor, which means it prevents the breakdown of the neurotransmitter acetylcholine in the synaptic cleft. This leads to an accumulation of acetylcholine and overstimulation of cholinergic receptors, causing a variety of symptoms such as muscle weakness, increased salivation, sweating, lacrimation, nausea, vomiting, and potentially fatal respiratory failure.

Paraoxon is also used in research and diagnostic settings to measure acetylcholinesterase activity. It can be used to determine the degree of inhibition of this enzyme by various chemicals or toxins, including other organophosphate compounds.

Hydroxylamines are organic compounds that contain a hydroxy group (-OH) and an amino group (-NH2) in their structure. More specifically, they have the functional group R-N-OH, where R represents a carbon-containing radical. Hydroxylamines can be considered as derivatives of ammonia (NH3), where one hydrogen atom is replaced by a hydroxy group.

These compounds are important in organic chemistry and biochemistry due to their ability to act as reducing agents, nitrogen donors, and intermediates in various chemical reactions. They can be found in some natural substances and are also synthesized for use in pharmaceuticals, agrochemicals, and other industrial applications.

Examples of hydroxylamines include:

* Hydroxylamine (NH2OH) itself, which is a colorless liquid at room temperature with an odor similar to ammonia.
* N-Methylhydroxylamine (CH3NHOH), which is a solid that can be used as a reducing agent and a nucleophile in organic synthesis.
* Phenylhydroxylamine (C6H5NHOH), which is a solid used as an intermediate in the production of dyes, pharmaceuticals, and other chemicals.

It's important to note that hydroxylamines can be unstable and potentially hazardous, so they should be handled with care during laboratory work or industrial processes.

Emission-Computed Tomography, Single-Photon (SPECT) is a type of nuclear medicine imaging procedure that generates detailed, three-dimensional images of the distribution of radioactive pharmaceuticals within the body. It uses gamma rays emitted by a radiopharmaceutical that is introduced into the patient's body, and a specialized gamma camera to detect these gamma rays and create tomographic images. The data obtained from the SPECT imaging can be used to diagnose various medical conditions, evaluate organ function, and guide treatment decisions. It is commonly used to image the heart, brain, and bones, among other organs and systems.

Boranes are a group of chemical compounds that contain only boron and hydrogen. The most well-known borane is BH3, also known as diborane. These compounds are highly reactive and have unusual structures, with the boron atoms bonded to each other in three-center, two-electron bonds. Boranes are used in research and industrial applications, including as reducing agents and catalysts. They are highly flammable and toxic, so they must be handled with care.

Butyrylcholinesterase (BChE) is an enzyme that catalyzes the hydrolysis of esters of choline, including butyrylcholine and acetylcholine. It is found in various tissues throughout the body, including the liver, brain, and plasma. BChE plays a role in the metabolism of certain drugs and neurotransmitters, and its activity can be inhibited by certain chemicals, such as organophosphate pesticides and nerve agents. Elevated levels of BChE have been found in some neurological disorders, while decreased levels have been associated with genetic deficiencies and liver disease.

Chemical processes refer to the various interactions and transformations that occur at the molecular or atomic level among chemicals, substances, or compounds. These processes involve changes in the structure, composition, energy state, or properties of the involved materials. They can be either spontaneous or induced and are governed by the laws of chemistry.

Some common examples of chemical processes include:

1. Chemical reactions: The transformation of one or more substances into different substances through a series of chemical interactions. These reactions might involve the breaking and forming of chemical bonds, resulting in new compounds with distinct properties.
2. Oxidation-reduction (redox) reactions: A specific type of chemical reaction where electrons are transferred between molecules or atoms, leading to changes in their oxidation states. These reactions often involve the transfer of oxygen or hydrogen atoms and play a crucial role in various biological and industrial processes.
3. Acid-base reactions: Chemical interactions between acids and bases, characterized by the transfer of a proton (H+) from an acid to a base. These reactions result in the formation of new compounds called salts and water.
4. Precipitation reactions: The formation of an insoluble solid (a precipitate) when two solutions are mixed together, often due to the creation of a new compound that cannot remain dissolved in the solvent.
5. Complexation: The formation of a complex between a central atom or ion and one or more ligands through coordinate covalent bonds. This process can lead to changes in the physical and chemical properties of both the central atom/ion and the ligand(s).
6. Electrolysis: A chemical process driven by an external electrical current, which induces chemical reactions at the electrodes immersed in a conducting solution (electrolyte). This process is used to produce various chemicals, such as hydrogen, chlorine, and sodium hydroxide.
7. Catalysis: The acceleration of a chemical reaction by a substance called a catalyst, which remains unchanged at the end of the reaction. Catalysts work by lowering the activation energy required for the reaction to occur, thereby increasing the rate of the process without being consumed in it.

Understanding chemical processes is essential for various fields, including chemistry, biology, medicine, materials science, and engineering, as they form the basis for numerous natural phenomena and technological applications.

Organophosphorus compounds are a class of chemical substances that contain phosphorus bonded to organic compounds. They are used in various applications, including as plasticizers, flame retardants, pesticides (insecticides, herbicides, and nerve gases), and solvents. In medicine, they are also used in the treatment of certain conditions such as glaucoma. However, organophosphorus compounds can be toxic to humans and animals, particularly those that affect the nervous system by inhibiting acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine. Exposure to these compounds can cause symptoms such as nausea, vomiting, muscle weakness, and in severe cases, respiratory failure and death.

Oximes are usually generated by the reaction of hydroxylamine with aldehydes (R−CH=O) or ketones (RRC=O). The term oxime dates ... O-substituted oximes form a closely related family of compounds. Amidoximes are oximes of amides (R1C(=O)NR2R3) with general ... In general, oximes exist as colorless crystals or as thick liquids and are poorly soluble in water. Therefore, oxime formation ... The hydrolysis of oximes proceeds easily by heating in the presence of various inorganic acids, and the oximes decompose into ...
Contact with gaseous, liquid, or solid phosgene oxime may result in severe skin or eye damage. Phosgene oxime has been found in ... Only people working near where phosgene oxime has been stored are at risk of being exposed to this substance. Exposure to high ... levels of phosgene oxime vapors may cause severe lung damage, and even death. ... Phosgene oxime was developed as a chemical warfare agent. ... What is phosgene oxime?. *What happens to phosgene oxime when ...
Other names: 9-Fluorenone oxime; 9H-Fluoren-9-one, oxime; Fluoren-9-one, oxime; Fluorenone-9-oxime; 9-Oximinofluorene ...
How phosgene oxime works *The extent of poisoning that phosgene oxime causes depends on the amount of phosgene oxime to which a ... Phosgene oxime is also known by its military designation, "CX." Where phosgene oxime is found and how it is used *Although ... Phosgene oxime (CX)plus icon *Facts About Phosgene Oxime. *Case Definition: Vesicant (Mustards, Dimethyl Sulfate, and Lewisite) ... Phosgene oxime is not found naturally in the environment. *Phosgene oxime vapor is heavier than air, so it will settle in low- ...
Phosgene oxime (CX) is an urticant or nettle agent that causes a corrosive type of skin and tissue injury. Although CX is often ... encoded search term (Phosgene Oxime Exposure) and Phosgene Oxime Exposure What to Read Next on Medscape ... Phosgene Oxime Exposure Workup. Updated: Oct 26, 2023 * Author: Erik D Schraga, MD; Chief Editor: Zygmunt F Dembek, PhD, MS, ... Phosgene oxime. Textbook of Military Medicine Part I: Medical Aspects of Chemical and Biological Warfare. 1997. 220-222. ...
Phosgene oxime (CX) is an urticant or nettle agent that causes a corrosive type of skin and tissue injury. Although CX is often ... encoded search term (Phosgene Oxime Exposure) and Phosgene Oxime Exposure What to Read Next on Medscape ... Phosgene Oxime Exposure. Updated: Oct 26, 2023 * Author: Erik D Schraga, MD; Chief Editor: Zygmunt F Dembek, PhD, MS, MPH, LHD ... Phosgene oxime (CX) is an urticant or nettle agent that causes a corrosive type of skin and tissue injury and may produce ...
The main active ingredient in both Interceptor® and Interceptor® Plus is milbemycin oxime. Milbemycin shifts chloride, a ... Interceptor® Plus contains two active ingredients, milbemycin oxime and praziquantel. Interceptor® Plus works to prevent ...
... l-hexamethylpropylene amine oxime (HMPAO) labelled leucocytes in combination with a 99mTc-methylene diphosphonate (MDP) bone ... Chronic osteomyelitis: diagnosis with technetium-99m-d, l-hexamethylpropylene amine oxime labelled leucocytes Eur J Nucl Med. ... To evaluate the diagnostic value of technetium-99m d, l-hexamethylpropylene amine oxime (HMPAO) labelled leucocytes in ...
How phosgene oxime works *The extent of poisoning that phosgene oxime causes depends on the amount of phosgene oxime to which a ... Phosgene oxime is also known by its military designation, "CX." Where phosgene oxime is found and how it is used *Although ... Phosgene oxime (CX)plus icon *Facts About Phosgene Oxime. *Case Definition: Vesicant (Mustards, Dimethyl Sulfate, and Lewisite) ... Phosgene oxime is not found naturally in the environment. *Phosgene oxime vapor is heavier than air, so it will settle in low- ...
... Pankaj V. ... chemoselective synthesis of chromenone-oximes as well as rearranged isoxazoles. ...
3-Dimethyl-2-butanone oxime; 3,3-dimethyl-butan-2-one oxime; 2-butanone, 3,3-dimethyl-, oxime ... Find manufacturers and suppliers for Pinacolone oxime, 2475-93-6. Synonyms: 3, ... 3,3-Dimethyl-2-butanone oxime; 3,3-dimethyl-butan-2-one oxime; 2-butanone, 3,3-dimethyl-, oxime ...
EP-0003301-A1 chemical patent summary.
2-furaldehyde oxime - cas 1121-47-7, synthesis, structure, density, melting point, boiling point ... Tags: melting point of 2-furaldehyde oxime - 1121-47-7 , boiling point of 2-furaldehyde oxime - 1121-47-7 , density of 2- ... furaldehyde oxime - 1121-47-7 , refractive index of 2-furaldehyde oxime - 1121-47-7 ...
Contrary to 2-PAM, the in silico study predicted lower binding free energies for both oximes. However, the detailed interaction ... Present study evaluates reactivation potency of two newly developed oximes, K456 and K733, against paraoxon (POX)-inhibited ... Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico ... In vitro studies showed higher intrinsic toxicities of both oximes than 2-PAM for AChE. No substantial reactivation of hBChE ...
1E)-(2-oxo-1(2H)-pyridinyl)ethanal oxime - C7H8N2O2, synthesis, structure, density, melting point, boiling point ... Tags: melting point of (1E)-(2-oxo-1(2H)-pyridinyl)ethanal oxime , boiling point of (1E)-(2-oxo-1(2H)-pyridinyl)ethanal oxime ... density of (1E)-(2-oxo-1(2H)-pyridinyl)ethanal oxime , refractive index of (1E)-(2-oxo-1(2H)-pyridinyl)ethanal oxime ...
A series of oxime ethers were prepared from (E, E)-cinnamaldoxime, crotonaldoxime, (syn)- benzaldoxime and p- ... Silver Oxide-Mediated Oxime Ether Synthesis. Author(s): Dimas Kubmarawa, JT. Barminas, Abdulraman OC Aliyu A series of oxime ...
A premium, single component, ready to use, neutral cure silicone sealant. It is low odour and moisture curing. Conforms to EN15651‐1,2 F EXT‐INT, G, 25LM. Benefits: Permanently elastic. Weatherproof. UV stable colours. Suitable for alkaline and metal surfaces. Low odour, low meko, safer to use. Anti‐fungal. Suitable fo
Propanal, 2-oxo-, 1-oxime. Change simulation parameters The result was obtained by a proprietary SIELC algorithm. It may ... Propanal, 2-oxo-, 1-oxime can be analyzed by this reverse phase (RP) HPLC method with simple conditions. The mobile phase ... Separation of Propanal, 2-oxo-, 1-oxime on Newcrom R1 HPLC column ...
Combining oxime-based [Mn6] clusters with cyanometalates: 1D chains of [Mn6] SMMs from [M(CN)2](-) (M = Au, Ag). ... Dive into the research topics of Combining oxime-based [Mn6] clusters with cyanometalates: 1D chains of [Mn6] SMMs from [M(CN) ...
... and hexamethylpropylene amine oxime (HMPAO)-are commonly used in human medicine and have been used previously ... and hexamethylpropylene amine oxime (HMPAO)-are commonly used in human medicine and have been used previously in dogs but ... Hexamethylpropylene Amine Oxime Single Photon Emission Computed Tomography. ...
This graph shows the total number of publications written about "Oximes" by people in this website by year, and whether "Oximes ... "Oximes" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject Headings) ... Below are the most recent publications written about "Oximes" by people in Profiles. ...
The most effective oxime against NIMP was novel oxime 20 demonstrating an odds ratio of 3.2 over treatment with 2-PAM. These ... Overall, the oximes were more effective reactivating inhibition from PXN than from NIMP. Out of all the oximes tested, 2-PAM ... After development of seizure-like behavior, atropine and one of four oximes, 2-PAM, novel oxime 15, 20, or 55 or Multisol ... The oxime currently approved for use in the U.S., pralidoxime (2-PAM), has limited efficacy penetrating the blood-brain barrier ...
silanes,Oxime silanes,22984-54-9,34206-40-1
The oximes can bind to their protein target in Mtb; however, they have poor Mtb permeability. By exploring another hit, 56, ... Benzoheterocyclic oxime carbamates. The anti-Mtb activity of a library of small polar molecules has been evaluated29,30 and ... In addition, the chemically synthesized oxime congeners of the carbamates were inactive against Mtb (MIC , 160 µM). It has been ... Benzoheterocyclic oxime carbamates active against Mycobacterium tuberculosis: synthesis, structure-activity relationship, ...
Cyclopentan-1-one oxime; N-Hydroxycyclopentan-1-imine; Cyclopentanone ...
Oximes of 4-(furan-2-yl)butan-2-one, 4-(furan-3-yl)butan-2-one, 4-(5-methylfuran-2-yl)butan-2-one, 4-(thiophen-2-yl)butan-2-one ...
Oxime compounds can reactivate OP inhibited cholinesterases by attaching to phosphorus, forming an oxime-phosphonate, which ... Oxime. Inhibitor. 7P1P-4IX. Comment. Componds like RRC=NOH, where R is an organic side-chain and R may be hydrogen, forming ... Type_inhibitor Report for: Oxime. Name. Class. ...
OXIME We felt the chemistry of the OXIME brand so intense that we developed the original One Page website into a company ... OXIME The OXIME brand received a logo, promotional materials, labels for products, graphics used in social media channels, a ... OXIME OXIME Industries online store - chemical raw materials, detergents, disinfectants have found their place on the virtual ... compatible with the visual communication of the OXIME brand. For the OXIME online store, we have also prepared product ...
  • Interceptor ® is a monthly medication for the prevention of heartworms in dogs and cats , containing the active ingredient milbemycin oxime. (petmd.com)
  • Interceptor ® Plus contains two active ingredients, milbemycin oxime and praziquantel. (petmd.com)
  • The main active ingredient in both Interceptor ® and Interceptor ® Plus is milbemycin oxime. (petmd.com)
  • Panoramis (Spinosad/Milbemycin Oxime) functions as both a worm treatment for dogs and a flea control medicine. (unitedpharmacies.com)
  • Milbemycin oxime exhibits anthelmintic properties. (unitedpharmacies.com)
  • Panoramis (Spinosad/Milbemycin Oxime) chewable tablets are available in 4 different strengths. (unitedpharmacies.com)
  • One variety contains 270mg of spinosad and 4.5mg of milbemycin oxime, and is used to treat dogs in the 4.6kg to 9kg weight range. (unitedpharmacies.com)
  • Panoramis (Spinosad/Milbemycin Oxime) tablets are only to be given to animals. (unitedpharmacies.com)
  • Interceptor Spectrum Tasty Brown (Milbemycin Oxime/Praziquantel) is a chewable medication used to control and prevent heartworm and intestinal worm infections in small dogs weighing less than four kilograms. (4nrx.md)
  • Follow the instructions of your veterinarian while using Interceptor Spectrum Tasty Brown (Milbemycin Oxime/Praziquantel) to get the most effective results. (4nrx.md)
  • What are the side effects of Interceptor Spectrum Tasty Brown (Milbemycin Oxime/Praziquantel)? (4nrx.md)
  • Interceptor Spectrum Tasty Brown (Milbemycin Oxime/Praziquantel) will not typically cause any side effects when used correctly. (4nrx.md)
  • Strictly follow all instructions provided to you by your veterinarian while using Interceptor Spectrum Tasty Brown (Milbemycin Oxime/Praziquantel). (4nrx.md)
  • Each plastic tube contains 0.25 mL of Milbemite Otic Solution as a 0.1% solution of milbemycin oxime. (expressvet.pharmacy)
  • Milbemycin oxime is a medication commonly used in veterinary medicine to prevent and treat various parasitic infections in dogs and cats. (79pets.com)
  • In this blog post, we will explore the benefits of using milbemycin oxime in pet medicine and how it can help keep your furry friend healthy and happy. (79pets.com)
  • How is Milbemycin Oxime given? (79pets.com)
  • Milbemycin oxime is typically given to dogs and cats as an oral medication, either in the form of a chewable tablet or a liquid suspension. (79pets.com)
  • Your veterinarian will give the correct milbemycin oxime dosage based on your pet's weight and the condition being treated. (79pets.com)
  • Milbemycin oxime is generally considered safe when used as directed, but like any medication, it can have potential side effects and interactions. (79pets.com)
  • Certain breeds of dogs may be more susceptible to side effects from milbemycin oxime, such as collies and other herding breeds. (79pets.com)
  • These breeds are known to have a genetic mutation that affects the metabolism of certain medications, including milbemycin oxime. (79pets.com)
  • If you have a collie or a herding breed, it's important to inform your veterinarian before giving your pet milbemycin oxime. (79pets.com)
  • It's important to also inform your veterinarian of any other medications your pet is taking, as milbemycin oxime may interact with other drugs. (79pets.com)
  • It's also important to note that pregnant, nursing or breeding animals should not be treated with milbemycin oxime, as it may cause harm to developing fetuses or newborns. (79pets.com)
  • Is there anything that needs to monitor with Milbemycin Oxime? (79pets.com)
  • There are a few things to keep in mind when monitoring your pet's use of milbemycin oxime. (79pets.com)
  • Third, it's important to keep track of your pet's weight, as the dosage of milbemycin oxime is based on weight. (79pets.com)
  • Fourth, it's essential to keep your pet on a monthly heartworm preventative, even if you are giving milbemycin oxime, as it may not protect against all types of worms. (79pets.com)
  • Lastly, it's essential to have your pet tested for heartworm disease before starting treatment with milbemycin oxime and to have them tested annually to ensure that the medication works effectively. (79pets.com)
  • The anthelmintic activity (destroying parasitic worms) of the active ingredient milbemycin oxime is believed to be a result of interfering with the invertebrates' neurotransmission. (1800petmeds.com)
  • To evaluate the diagnostic value of technetium-99m d, l-hexamethylpropylene amine oxime (HMPAO) labelled leucocytes in combination with a 99mTc-methylene diphosphonate (MDP) bone scan in the detection of chronic osteomyelitis, we retrospectively reviewed 55 patients. (nih.gov)
  • Two 99mTc-labeled single photon emission computed tomography (SPECT) cerebral blood flow tracers-ethylcysteinate dimer (ECD) and hexamethylpropylene amine oxime (HMPAO)-are commonly used in human medicine and have been used previously in dogs but intrasubject comparison of both tracers in dogs is lacking. (avmi.net)
  • O-substituted oximes form a closely related family of compounds. (wikipedia.org)
  • Oximes can also be obtained from reaction of nitrites such as isoamyl nitrite with compounds containing an acidic hydrogen atom. (wikipedia.org)
  • Oxime compounds are used as antidotes for nerve agents. (wikipedia.org)
  • Phosgene oxime in the air may also react with moisture in clouds or rain and be broken down into other compounds. (cdc.gov)
  • How might I be exposed to phosgene oxime? (cdc.gov)
  • There are no studies on the health effects of children exposed to phosgene oxime. (cdc.gov)
  • It is likely that the health effects seen in children exposed to phosgene oxime would be similar to the effects seen in adults. (cdc.gov)
  • Most families will not be exposed to phosgene oxime. (cdc.gov)
  • Is there a medical test to show whether I've been exposed to phosgene oxime? (cdc.gov)
  • There are no tests to positively determine whether you have been exposed to phosgene oxime. (cdc.gov)
  • If you suspect that you may have been exposed to phosgene oxime, a chest X-ray may be the quickest way to determine if your lungs have been damaged. (cdc.gov)
  • been exposed to phosgene oxime. (cdc.gov)
  • Showing these signs or symptoms does not necessarily mean that a person has been exposed to phosgene oxime. (cdc.gov)
  • We do not know what happens if you swallow phosgene oxime liquid or solid. (cdc.gov)
  • If phosgene oxime liquid is released into water, people can be exposed by touching or drinking water that contains phosgene oxime. (cdc.gov)
  • If phosgene oxime liquid comes into contact with food, people can be exposed by eating the contaminated food. (cdc.gov)
  • Oxime extractants 3- tert -butyl-2-hydroxy-5-methyl benzaldehyde oxime ( HL 1 ) and 3- tert -butyl-2-hydroxy-5-methoxy benzaldehyde oxime ( HL 2 ) were synthesized and characterized by conventional spectroscopic methods. (analchemres.org)
  • In general, oximes exist as colorless crystals or as thick liquids and are poorly soluble in water. (wikipedia.org)
  • Phosgene oxime is colorless in its solid form and yellowish-brown when it is a liquid. (cdc.gov)
  • Treatment against acute OP toxicity includes oximes which reactivate phosphorylated acetylcholinesterase (AChE) restoring enzymatic activity. (msstate.edu)
  • A hypothesis that the temperature affects the oximes ability to reactivate phosphorylated cholinesterases has been proposed. (bmc-rm.org)
  • Oximes have three characteristic bands in the infrared spectrum, whose wavelengths corresponding to the stretching vibrations of its three types of bonds: 3600 cm−1 (O−H), 1665 cm−1 (C=N) and 945 cm−1 (N−O). In aqueous solution, aliphatic oximes are 102- to 103-fold more resistant to hydrolysis than analogous hydrazones. (wikipedia.org)
  • The conversion of a series of dicarbonyls to oximes in aqueous solution and from gas-phase sampling was achieved using O-tert-butylhydroxylamine hydrochloride (TBOX). (cdc.gov)
  • Phosgene oxime has a disagreeable, irritating odor. (cdc.gov)
  • Lewisite may have a geranium-like odor, and phosgene oxime has been described simply as irritating. (msdmanuals.com)
  • Present study evaluates reactivation potency of two newly developed oximes, K456 and K733, against paraoxon (POX)-inhibited human-RBC-AChE and human-plasma-BChE in comparison to reported reactivator, pralidoxime (2-PAM). (simulations-plus.com)
  • This research investigated any differences in oxime reactivation among four age/sex groups and also survivability in adult female Sprague Dawley rats challenged with a lethal dose of OP. Initially in in vitro experiments, paraoxon (PXN) and a nerve agent (sarin) surrogate, 4-nitrophenyl isopropyl methylphosphonate (NIMP), were incubated with pooled rat brain homogenate from four sex/age groups: adult male or female, and 12-day old male or female rats. (msstate.edu)
  • Reactivation was performed utilizing 2-PAM or one of three novel oximes (15, 20, or 55), alone or in combination, and AChE activity was measured in a spectrophotometric assay. (msstate.edu)
  • Out of all the oximes tested, 2-PAM showed the greatest reactivation percentages. (msstate.edu)
  • Of the novel oximes, 15 and 20 displayed the highest reactivation against PXN and NIMP, respectively. (msstate.edu)
  • No statistical difference was detected in reactivation for any oxime among the age/sex groups. (msstate.edu)
  • Cutaneous exposure to vesicant phosgene oxime: Acute effects on the skin and systemic toxicity. (medscape.com)
  • Oximes for acute organophosphate pesticide poisoning. (bmc-rm.org)
  • Exposure to high levels of phosgene oxime vapors may cause severe lung damage, and even death. (cdc.gov)
  • The effects of long-term exposure to phosgene oxime in humans are not known. (cdc.gov)
  • We do not know if exposure to phosgene oxime might cause reproductive effects in humans. (cdc.gov)
  • There is no information to determine whether exposure to phosgene oxime might cause cancer. (cdc.gov)
  • We do not know if exposure to phosgene oxime would result in birth defects or other developmental effects in people and no information exist from animal studies. (cdc.gov)
  • How can families reduce the risk of exposure to phosgene oxime? (cdc.gov)
  • Inhaling or directly contacting significant amounts of We do not know if exposure to phosgene oxime would result phosgene oxime can result in death. (cdc.gov)
  • People's risk for exposure depends on how close they are to the place where the phosgene oxime was released. (cdc.gov)
  • The extent of poisoning that phosgene oxime causes depends on the amount of phosgene oxime to which a person is exposed, how the person is exposed, and the length of time of the exposure. (cdc.gov)
  • Signs and symptoms occur immediately following a phosgene oxime exposure. (cdc.gov)
  • Quickly moving to an area where fresh air is available is highly effective in reducing exposure to phosgene oxime. (cdc.gov)
  • Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models. (medscape.com)
  • Pain occurring at or shortly after exposure suggests to first responders that Lewisite or phosgene oxime is the chemical agent involved. (msdmanuals.com)
  • Our laboratory has developed novel substituted phenoxyalkyl pyridinium oximes (US Patent 9,227,937) designed to more effectively penetrate the central nervous system. (msstate.edu)
  • These data indicate that the novel pyridinium oximes are equally efficacious reactivators in adult and juvenile rats of both sexes and enhance survivability against lethal-level OP toxicity as compared to 2-PAM in adult female rats. (msstate.edu)
  • Garcia, Jason Michael, "Efficacy of Novel Pyridinium Oximes against Two Organophosphates in Female Sprague Dawley Rats" (2019). (msstate.edu)
  • Phosgene oxime is a type of agent called an urticant or nettle agent. (cdc.gov)
  • Singh SK, Klein JA, Wright HN, Tewari-Singh N. Phosgene oxime: a highly toxic urticant and emerging chemical threat. (medscape.com)
  • Phosgene oxime (CX) is an urticant or nettle agent that causes a corrosive type of skin and tissue injury and may produce systemic effects. (medscape.com)
  • After development of seizure-like behavior, atropine and one of four oximes, 2-PAM, novel oxime 15, 20, or 55 or Multisol vehicle was administered. (msstate.edu)
  • The goal of study was the determination of the ionization constants for the oximes - cholinesterases reactivators in aqueous solutions at different temperatures. (bmc-rm.org)
  • Spectrophotometric and electrochemical study of protolytic equilibria of some oximes-acetylcholinesterase reactivators. (bmc-rm.org)
  • The hydrolysis of oximes proceeds easily by heating in the presence of various inorganic acids, and the oximes decompose into the corresponding ketones or aldehydes, and hydroxylamines. (wikipedia.org)
  • Proper functionalization of α-haloketoximes and a change of conditions also allowed the chemoselective synthesis of chromenone-oximes as well as rearranged isoxazoles. (organic-chemistry.org)
  • Overall, the oximes were more effective reactivating inhibition from PXN than from NIMP. (msstate.edu)
  • Some advantages of using this derivatization agent include: aqueous reactions, lower molecular weight oximes, and shortened oxime-formation reaction time. (cdc.gov)
  • In vitro studies showed higher intrinsic toxicities of both oximes than 2-PAM for AChE. (simulations-plus.com)
  • However, the detailed interaction study revealed inability of oximes to interact with catalytic anionic site of AChE and hBChE in contrast to 2-PAM. (simulations-plus.com)
  • Charged oximes poorly cross the blood brain barrier. (inra.fr)
  • Phosgene oxime vapors are broken down in the atmosphere by reacting with substances commonly found in the air, but this is a very slow process. (cdc.gov)
  • In the presence of sulfuric acid catalyst, the oxime undergoes the Beckmann rearrangement to give the cyclic amide caprolactam: Oximes are commonly used as ligands and sequestering agents for metal ions. (wikipedia.org)
  • Skin contact with phosgene oxime will cause swelling and itching hives that can also result in immediate and painful skin damage. (cdc.gov)
  • Certain amidoximes react with benzenesulfonyl chloride to make substituted ureas in the Tiemann rearrangement: In their largest application, an oxime is an intermediate in the industrial production of caprolactam, a precursor to Nylon 6. (wikipedia.org)
  • [ 11 ] Possible mechanisms of toxicity include necrotizing effects of the chloride component or a direct effect of the oxime or carbonyl groups. (medscape.com)
  • A series of oxime ethers were prepared from (E, E)-cinnamaldoxime, crotonaldoxime, (syn)- benzaldoxime and p-methoxybenzaldoxime by reaction with methyl iodide, ethyl bromide and benzyl chloride with silver oxide as base and catalyst. (scholarsresearchlibrary.com)
  • Phosgene oxime can penetrate clothing and rubber faster than other chemical warfare agents. (cdc.gov)
  • In organic chemistry, an oxime is an organic compound belonging to the imines, with the general formula RR'C=N−OH, where R is an organic side-chain and R' may be hydrogen, forming an aldoxime, or another organic group, forming a ketoxime. (wikipedia.org)
  • Oximes are usually generated by the reaction of hydroxylamine with aldehydes (R−CH=O) or ketones (RR'C=O). The term oxime dates back to the 19th century, a combination of the words oxygen and imine. (wikipedia.org)
  • The oxime currently approved for use in the U.S., pralidoxime (2-PAM), has limited efficacy penetrating the blood-brain barrier. (msstate.edu)
  • We felt the chemistry of the OXIME brand so intense that we developed the original One Page website into a company website with several tabs, an offer basket for easy inquiries and a CMS panel for adding news and products. (dotred.pl)
  • Skin contact with phosgene oxime causes intense, stinging ("nettling") pain and whitening within 5 to 20 seconds. (msdmanuals.com)
  • Oximes can be synthesized by condensation of an aldehyde or a ketone with hydroxylamine. (wikipedia.org)
  • A series of eleven hydroxy and methoxy substituted new chalcone oximes ( 2a-2k ) were synthesized by the condensation of chalcone ( 1a-1k ) with hydroxylamine hydrochloride in pyridine. (acgpubs.org)
  • Available at https://emergency.cdc.gov/agent/phosgene-oxime/basics/facts.asp . (medscape.com)
  • Phosgene oxime was developed as a chemical warfare agent. (cdc.gov)
  • Phosgene oxime is a manufactured chemical that was developed as a potential chemical warfare agent, but its use on the battlefield has never been documented. (cdc.gov)
  • Most of the phosgene oxime in developed as a potential chemical warfare agent, but its use soil will be broken down upon contact with moisture or be on the battlefield has never been documented. (cdc.gov)
  • Phosgene oxime is a manufactured chemical warfare agent. (cdc.gov)
  • Although phosgene oxime has been produced only as a chemical warfare agent, it has never been used during wartime. (cdc.gov)
  • Therefore, oxime formation can be used for the identification of ketone or aldehyde functional groups. (wikipedia.org)
  • Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents. (bvsalud.org)
  • Goswami DG, Agarwal R, Tewari-Singh N. Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite. (medscape.com)
  • The reduction of oximes by sodium metal, sodium amalgam, hydrogenation, or reaction with hydride reagents produces amines. (wikipedia.org)
  • The Ponzio reaction (1906) concerning the conversion of m-nitrobenzaldoxime to m-nitrophenyldinitromethane using dinitrogen tetroxide was the result of research into TNT analogues: In the Neber rearrangement certain oximes are converted to the corresponding alpha-amino ketones. (wikipedia.org)
  • When released to air, phosgene oxime will exist solely in the gas-phase. (cdc.gov)
  • Phosgene oxime will react with water or be broken down into other products by bacteria. (cdc.gov)
  • The OXIME brand received a logo, promotional materials, labels for products, graphics used in social media channels, a website and an online store from DotRed. (dotred.pl)
  • 21] G. A. Kordosky, K. D. MacKay, R. B. Sudderth, J. M. Sierakoski, Liquid-liquid recovery of copper values using alpha-hydroxy oximes, US Patent US4507268 A (1965). (analchemres.org)
  • In general, oximes can be changed to the corresponding amide derivatives by treatment with various acids. (wikipedia.org)
  • About half of the world's supply of cyclohexanone, more than a million tonnes annually, is converted to the oxime. (wikipedia.org)
  • If the two side-chains on the central carbon are different from each other-either an aldoxime, or a ketoxime with two different "R" groups-the oxime can often have two different geometric stereoisomeric forms according to the E/Z configuration. (wikipedia.org)
  • Contact with gaseous, liquid, or solid phosgene oxime may result in severe skin or eye damage. (cdc.gov)
  • Phosgene oxime is also referred to as a corrosive agent because of the type of skin and tissue damage it causes. (cdc.gov)
  • If phosgene oxime gas is released into the air, people can be exposed through skin contact or eye contact. (cdc.gov)
  • Phosgene oxime produces instant and almost unbearable pain on exposed skin and exposed eyes. (cdc.gov)
  • Absorbing phosgene oxime through the skin or inhaling it may result in fluid in the lungs (pulmonary edema) with symptoms of shortness of breath and cough. (cdc.gov)